［1］Frank RN. Diabetic retinopathy［J］. N Engl J Med, 2004, 350(1):
48-58.
［2］Gariano RF, Gardner TW. Retinal angiogenesis in development and
disease［J］. Nature,2005,438(7070):960-6.
［3］Martin PM, Roon P, Van Ells TK, et al. Death of retinal neurons in
streptozotocin-induced diabetic mice［J］. Invest Ophthalmol Vis Sci,
2004,45(9):3330-6.
［4］Nakagawa T, Sato W, Glushakova O, et al. Diabetic endothelial
nitric oxide synthase knockout mice develop advanced diabetic
nephropathy［J］. J Am Soc Nephrol,2007,18(2):539-50.
［5］Zhao HJ, Wang S, Cheng H, et al. Endothelial nitric oxide synthase
deficiency produces accelerated nephropathy in diabetic mice［J］. J
Am Soc Nephrol,2006,17(10):2664-9.
［6］Lei B, Yao G, Zhang K, et al. Study of rod- and cone-driven
oscillatory potentials in mice［J］. Invest Ophthalmol Vis Sci, 2006,
47(6):2732-8.
［7］Layton CJ, Safa R, Osborne NN. Oscillatory potentials and the
b-wave: partial masking and interdependence in dark adaptation
and diabetes in the rat［J］. Graefes Arch Clin Exp Ophthalmol,
2007,245(9):1335-45.
［8］Li Q, Zemel E, Miller B, et al. Early retinal damage in experimental
diabetes: electroretinographical and morphological observations［J］.
Exp Eye Res,2002,74(5):615-25.
［9］Neckell A. Adaptometry in diabetic patients［J］. Oftalmologia,2007, 51
(3):95-7.
［10］Awata T, Neda T, Iizuka H, et al. Endothelial nitric oxide synthase
gene is associated with diabetic macular edema in type2diabetes
［J］. Diabetes Care,2004,27(9):2184-90.
［11］Ezzidi I, Mtiraoui N, Mohamed MB, et al. Endothelial nitric oxide
synthase Glu298Asp,4b/a, and T-786C polymorphisms in type2
diabetic retinopathy［J］. Clin Endocrinol (Oxf),2008,68(4):542-6.
［12］Chen Y, Huang H, Zhou J, et al. Polymorphism of the endothelial
nitric oxide synthase gene is associated with diabetic retinopathy in
a cohort of West Africans［J］. Mol Vis,2007,13:2142-7.
［13］Durante W, Sen AK, Sunahara FA. Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats［J］.
Br J Pharmacol,1988,94(2):463-8.
［14］Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent
diabetes mellitus［J］. J Am Coll Cardiol,1996,27(3):567-74.
［15］Dawson VL, Dawson TM. Nitric oxide neurotoxicity［J］. J Chem
Neuroanat,1996,10(3-4):179-90.
［16］Al-Shabrawey M, El-Remessy A, Gu X, et al. Normal vascular
development in mice deficient in endothelial NO synthase: possible
role of neuronal NO synthase ［J］. Mol Vis,2003,9:549-58.
［17］Liu VW, Huang PL. Cardiovascular roles of nitric oxide: a review
of insights from nitric oxide synthase gene disrupted mice［J］.
Cardiovasc Res,2008,77(1):19-29.
［18］Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular
and neural apoptosis to the pathology of diabetic retinopathy［J］.
Invest Ophthalmol Vis Sci,2011,52(2):1156-63.
［19］Ozawa Y, Kurihara T, Sasaki M, et al. Neural degeneration in the
retina of the streptozotocin-induced type 1diabetes model［J］. Exp
Diabetes Res,2011,2011:108328 |
